Clinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis despite prior methotrexate therapy: final results of the randomized GO-FORTH trial

Objective: To evaluate the safety and efficacy of golimumab + methotrexate (MTX) in Japanese patients with active rheumatoid arthritis (RA). Methods: Japanese patients with active RA despite MTX were randomized to placebo + MTX (Group 1, n = 88), golimumab 50 mg + MTX (Group 2, n = 86), or golimumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yoshiya, Harigai, Masayoshi, Takeuchi, Tsutomu, Yamanaka, Hisashi, Ishiguro, Naoki, Yamamoto, Kazuhiko, Miyasaka, Nobuyuki, Koike, Takao, Baker, Daniel, Ishii, Yutaka, Yoshinari, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924564/
https://www.ncbi.nlm.nih.gov/pubmed/26474192
http://dx.doi.org/10.3109/14397595.2015.1109762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924564/
https://www.ncbi.nlm.nih.gov/pubmed/26474192
http://dx.doi.org/10.3109/14397595.2015.1109762

Ejemplares similares